Product Information
BEPOTASTINE 1.5% EYE DROP is a generic product labeled by Bausch & Lomb Incorporated, priced at $11.5649 per ML under NDC 24208063005. Its NADAC has been published 254 times since Aug 18, 2021.
The High Outlier badge above means this manufacturer's average price in the bepotastine besilate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208063005
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
BEPOTASTINE BESILATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022288On Market Since
5/28/2021
Pharmacological Classes
Price Statistics
The NADAC for BEPOTASTINE 1.5% EYE DROP has been published 254 times since Aug 18, 2021, and over the history we have for it it has declined 69.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.5649 per ML |
|---|---|
| All-time high | $38.6198 (Dec 15, 2021) |
| All-time low | $11.5649 (Jun 17, 2026) |
| 52-week high | $15.9426 |
| 52-week low | $11.5649 |
| Median price | $18.9606 |
| Average price | $20.9964 |
| Largest weekly change | +49.6% (Nov 20, 2024) |
| Weeks tracked | 254 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BEPOTASTINE 1.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for BEPOTASTINE 1.5% EYE DROP, manufactured by Bausch & Lomb Incorporated, is $11.5649 per ML (NDC 24208063005), effective Jun 24, 2026.
How has the price of BEPOTASTINE 1.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for BEPOTASTINE 1.5% EYE DROP has declined 69.7%. It has been tracked across 254 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for BEPOTASTINE 1.5% EYE DROP?
Since Aug 18, 2021, the NADAC for BEPOTASTINE 1.5% EYE DROP has ranged from a low of $11.5649 (Jun 17, 2026) to a high of $38.6198 (Dec 15, 2021), with a median of $18.9606 per ML.
Are there cheaper alternatives to BEPOTASTINE 1.5% EYE DROP?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BEPOTASTINE 1.5% EYE DROP, is $8.5569 per ML — about 26% below BEPOTASTINE 1.5% EYE DROP.
Who manufactures BEPOTASTINE 1.5% EYE DROP?
BEPOTASTINE 1.5% EYE DROP (NDC 24208063005) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.
Related Drugs
Same classification